Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Learn when to mix SP 500 and bond funds in retirement to balance risk and growth. This brief guide covers practical timing rules to help you stay on track.
28,655 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Rising APRs are transforming solar financing, exposing homeowners to longer paybacks and higher total costs. This rep...
Google has struck a major AI compute deal with SpaceX, paying about $920 million per month from late 2026 through mid...
A famous AI investor argues the economics of AI deployment could shift cash flow toward infrastructure vendors like N...
As AI reshapes the job landscape in early 2026, workers face displacement and investors recalibrate. This report expl...
Braze beat Q4 expectations with $205.17 million in revenue and 27.9% annual growth, as analysts weigh the AI-driven g...
Ethereum faces renewed selling pressure as ether trader sentiment falls to its lowest level in three years. The signa...
Oracle’s stock is enduring its worst stretch in a generation as the AI debate intensifies, cloud growth battles margi...
A memory-focused stock surged from about $40 to near $2,000 this year, fueling debate over whether the run can endure...
Aston Martin plans a major workforce reduction of up to 20%, affecting about 600 roles from a 3,000-employee base. Th...
Mortgage rates jump to the mid-6% range as geopolitical risk rises, pushing borrowing costs closer than 7% and compli...
A synthetic contract puts SpaceX at a $2.4 trillion implied IPO, a figure that dwarfs Facebook's listing and tests ho...